
PubMed:32472611
Novel dose escalation to predict treatment with hydroxyurea (NDEPTH): A randomized controlled trial of a dose-prediction equation to determine maximum tolerated dose of hydroxyurea in pediatric sickle cell disease.
|
projects
Unselected (6) / annnotation (6) | Selected (0) / annnotation (0) | |
|
|
|